News | March 21, 2024
IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
Pharma Solutions operates 10 research and development and/or production sites globally
Pharma Solutions operates 10 research and development and/or production sites globally
The collaboration brings a seamless digital experience to more formulators worldwide
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Farxiga is expected to have such a strong influence on the market due to the impressive results
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)